Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia [Phase 1, Phase 2]

View source ↗

Summary

This Clinical Trials update reports on a Phase I/II randomized study evaluating hydroxyurea with or without clotrimazole in patients with sickle cell disease, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole (clotrimazole)
  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: University of North Carolina | Conditions: Sickle Cell Anemia | Phase 1, Phase 2 | Status: COMPLETED